UNSPSC 51201612: Mumps virus vaccine

This classification denotes a vaccine for an acute infectious disease caused by rubulavirus, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected.

UNSPSC 51201612 Mumps virus vaccine is a Commodity code under which state health departments procure viral vaccines for public health programs, though recent activity shows limited solicitation volume. The code nominally covers mumps immunization products, but the single recent opportunity posted under this code — a Mississippi State Department of Health sole source notice for Yellow Fever Vaccine from Sanofi Pasteur, Inc., due August 3, 2026 — indicates either misclassification or sparse actual mumps vaccine procurement activity in the state and local market. State health departments are the primary issuing bodies for vaccine procurement under this code tier, working to meet immunization program requirements and public health mandates.

The sole recent opportunity is concentrated in the Southeast, with Mississippi State Department of Health as the visible buyer. The notice is structured as a proposed sole source purchase rather than a competitive RFP or IFB, meaning objections to sole source designation — not bids on competing products — form the response mechanism; interested vendors must demonstrate alternative supply availability by the August 3, 2026 deadline with written documentation to Cynthia Brasher at the Mississippi State Department of Health Purchasing Department. The notice provides no quantity, contract term, or estimated value. The mismatch between the code's stated scope (mumps vaccine) and the actual opportunity posted (yellow fever vaccine) suggests limited current state and local procurement activity specifically for mumps virus vaccine products, or that issuing bodies are tagging vaccine purchases inconsistently across UNSPSC categories.